Results 241 to 250 of about 42,366 (268)

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

Lancet, The, 2012
Paulus Kirchhof, Ursula Ravens, Karl Wegscheider   +2 more
exaly  

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation

JAMA - Journal of the American Medical Association, 2005
Nassir F Marrouche, Atul Verma, Mandeep Bhargava   +2 more
exaly  

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)

JAMA - Journal of the American Medical Association, 2014
Carlos A Morillo, Atul Verma, Stuart J Connolly   +2 more
exaly  

Atria-selective antiarrhythmic drugs in need of alliance partners

Pharmacological Research, 2019
Rémi Peyronnet, Ursula Ravens
exaly  

New Antiarrhythmic Drugs and New Targets for Antiarrhythmic Drugs

Saljic, Arnela, Dobrev, Dobromir, Heijman, Jordi   +2 more
openaire   +1 more source

CYCLIC ADENOSINE MONOPHOSPHATE, VENTRICULAR FIBRILLATION, AND ANTIARRHYTHMIC DRUGS

Lancet, The, 1976
exaly  

Antiarrhythmic Drugs

2006
R.S. Vardanyan, V.J. Hruby
  +4 more sources

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
exaly  

A Comparison of Seven Antiarrhythmic Drugs in Patients with Ventricular Tachyarrhythmias

New England Journal of Medicine, 1993
exaly  

Antiarrhythmic Drugs

2020
Jordi Heijman, Dobromir Dobrev
openaire   +1 more source